Quick Answer
Xenon Pharmaceuticals Inc. reported Shares Outstanding of 80.01 million shares for fiscal year 2025.
Xenon Pharmaceuticals Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 80.01M | +4.7% |
| 2024 | 76.42M | +1.4% |
| 2023 | 75.37M | +20.4% |
| 2022 | 62.59M | +21.2% |
| 2021 | 51.63M | +47.5% |
| 2020 | 35.01M | +24.4% |
| 2019 | 28.14M | +9.3% |
| 2018 | 25.75M | +43.1% |
| 2017 | 18.00M | +0.4% |
| 2016 | 17.93M | +24.6% |
| 2015 | 14.39M | +1.4% |
| 2014 | 14.18M | +0.0% |
| 2014 | 14.18M | +954.7% |
| 2013 | 1.34M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 77.12M | +1.7% | +0.2% |
| June 30, 2025 | 76.94M | +1.7% | +0.5% |
| March 31, 2025 | 76.59M | +1.5% | +0.2% |
| December 31, 2024 | 76.42M | +1.4% | +0.8% |
| September 30, 2024 | 75.79M | +16.6% | +0.2% |
| June 30, 2024 | 75.67M | +18.8% | +0.3% |
| March 31, 2024 | 75.46M | +19.6% | +0.1% |
| December 31, 2023 | 75.37M | +20.4% | +16.0% |
- Xenon Pharmaceuticals Inc. showed an increase of +4.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2013–2025 period, Xenon Pharmaceuticals Inc.’s shares outstanding has grown by 5850.4% (from 1.34 million shares to 80.01 million shares).
- The most recent figure is from Xenon Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: